In this health video learn how kidney cancer can be devastating, leaving patients and their families short on time. A new drug is giving the gift of time.
Read the full transcript »
Jennifer Matthews: Robert Skinner has been battling cancer for five years. Robert Skinner: Some people, when they're diagnosed with cancer, get very upset because they say, why me? Why not? Jennifer Matthews: Joe Guthro is fighting cancer as well. He has one goal in mind. Joe Guthro: To live a few more years Jennifer Matthews: Both men have advanced kidney cancer, a disease Dr. Anil Kapoor, says grim prognosis. Anil Kapoor: Often, patients would choose not to go on anything knowing that they have metastatic cancer because the success rate was so poor. Jennifer Matthews: But that's changing with a new drug called Temsirolimus. It regulates the production, growth and survival of cells. Anil Kapoor: What this drug, Temsirolimus, does is help patients live longer. Jennifer Matthews: In a recent study, patients on the drug nearly doubled their survival from six months to eleven months compared to the standard treatment, interferon. Anil Kapoor: You live four or five months longer that doesn't seem like a big deal. But when you have metastatic cancer, it means the world end. Jennifer Matthews: And it preserves quality of life, an important benefit. Joe has gained a healthy 45 pounds on the drug. His sister Loretta is hopeful. Loretta Kotska: You don't give up, as long as he's well and taken care of whatever time we have together is incredible. Jennifer Matthews: Rob partner, Paul, agrees. Paul Bonehill : It's very significant. When you love someone, you don't want them to go. Jennifer Matthews: Rob still wakes up every day fighting. Robert Skinner: I put my feet on the ground. If I can stand up, I say I made it. Jennifer Matthews: With his spirit and the sense of humor intact. This is Jennifer Matthews reporting.
Copyright © 2005 - 2014 Healthline Networks, Inc. All rights reserved for Healthline.